Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2017-05-02 (9 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAINT-AUBIN-D'AUBIGNE (35250), Ille-et-Vilaine
PHARMACIE SAINT AUBINOISE : revenue, balance sheet and financial ratios
PHARMACIE SAINT AUBINOISE is a French company
founded 9 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINT-AUBIN-D'AUBIGNE (35250),
this company of category PME
shows in 2024 a revenue of 1.6 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE SAINT AUBINOISE (SIREN 829357318)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
Revenue
N/C
1 563 505 €
1 530 516 €
N/C
N/C
N/C
N/C
N/C
Net income
36 001 €
23 188 €
17 561 €
66 190 €
51 536 €
44 276 €
66 681 €
-60 165 €
EBITDA
N/C
53 877 €
79 728 €
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
1.5%
1.1%
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE SAINT AUBINOISE generates positive net income of 36 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
36 001 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 186%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 31%. The balance between equity and debt is satisfactory.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
185.598%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
30.805%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE SAINT AUBINOISE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
2687.754
934.329
629.036
444.939
302.759
261.163
222.544
185.598
Financial autonomy
3.259
8.927
12.21
16.382
22.126
24.534
27.667
30.805
Repayment capacity
None
None
None
None
None
10.409
15.075
None
Cash flow / Revenue
None%
None%
None%
None%
None%
4.668%
2.906%
None%
Sector positioning
Debt ratio
185.62025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average
In 2025, the debt ratio of PHARMACIE SAINT AUBINOISE (185.60) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
30.8%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average
In 2025, the financial autonomy of PHARMACIE SAINT AUBINOISE (30.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
15.07 years2024
2023
2024
Q1: 0.52 years
Med: 3.19 years
Q3: 7.6 years
Watch
In 2024, the repayment capacity of PHARMACIE SAINT AUBINOISE (15.07) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 135.20. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
135.202
Liquidity indicators evolution PHARMACIE SAINT AUBINOISE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
165.936
183.431
142.869
163.042
160.36
160.268
153.393
135.202
Interest coverage
None
None
None
None
None
6.845
9.087
None
Sector positioning
Liquidity ratio
135.22025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Average-10 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE SAINT AUBINOISE (135.20) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
9.09x2024
2023
2024
Q1: 0.0x
Med: 2.35x
Q3: 7.73x
Excellent
In 2024, the interest coverage of PHARMACIE SAINT AUBINOISE (9.1x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE SAINT AUBINOISE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
0 €
0 €
0 €
0 €
0 €
142 889 €
111 775 €
0 €
Inventory turnover (days)
0
0
0
0
0
30
23
0
Customer payment term (days)
0
0
0
0
0
7
6
0
Supplier payment term (days)
0
0
0
0
0
28
25
0
Positioning of PHARMACIE SAINT AUBINOISE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE SAINT AUBINOISE is estimated at
571 880 €
(range 388 080€ - 897 358€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
388k€571k€897k€
571 880 €Range: 388 080€ - 897 358€
NAF 5 année 2025
Valuation method used
Net Income Multiple
36 001 €
×
15.9x
=571 880 €
Range: 388 081€ - 897 359€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE SAINT AUBINOISE with other companies in the same sector:
Frequently asked questions about PHARMACIE SAINT AUBINOISE
What is the revenue of PHARMACIE SAINT AUBINOISE ?
The revenue of PHARMACIE SAINT AUBINOISE in 2024 is 1.6 M€.
Is PHARMACIE SAINT AUBINOISE profitable?
Yes, PHARMACIE SAINT AUBINOISE generated a net profit of 36 k€ in 2025.
Where is the headquarters of PHARMACIE SAINT AUBINOISE ?
The headquarters of PHARMACIE SAINT AUBINOISE is located in SAINT-AUBIN-D'AUBIGNE (35250), in the department Ille-et-Vilaine.
Where to find the tax return of PHARMACIE SAINT AUBINOISE ?
The tax return of PHARMACIE SAINT AUBINOISE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE SAINT AUBINOISE operate?
PHARMACIE SAINT AUBINOISE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart